Like to Know More?

  • This field is for validation purposes and should be left unchanged.

For More Information

CTSNet
AATB
CryoVeinPC_ProductHeader_600x200

Pediatric Conduits

CryoVein-PC

Femoral Vein vs. PTFE Graft: Stage I Norwood1

For patients receiving a Femoral Vein:

  • Better growth and development of branch pulmonary arteries
  • Improved Nakata Index
  • No recognizable adverse events with tissue
Variable Valved Femoral Vein
Homograft (n=14)
Gore-Tex Graft
(n=34)
p=Value (<0.05)
Age of pre Glenn (weeks) 16.55 ± 4.34 14.59 ± 3.45 NS
Nakata Index
at birth 110.19 ± 45.64 83.8 ± 23.67 NS
at pre Glenn 364.84 ± 299.13 162.46 ± 74.5 0.02
PA size (mm)
RPA 7.81 ± 3.62 5.05 ± 1.19 0.02
LPA 7.22 ± 2.07 5.66 ± 1.96 0.03
PA growth velocity (mm/week)
RPA 0.22 ± 0.16 0.13 ± 0.07 0.03
LPA 0.2 ± 0.12 0.17 ± 0.11 NS

Saphenous Vein vs. ePTFE Graft: Stage I Norwood2

For patients receiving a Saphenous Vein:

  • Better RV systolic function pre-Glen
  • No regurgitation or functional deterioration with tissue
RV-Ejection-Fraction

Ordering Information

Catalogue Number Size Range
PCFV00 – Femoral Vein Allograft without Competent Valve
PCFV10 – Femoral Vein Allograft with Competent Valve
Diameter: 4mm+ OD
Length: 12cm-16cm
PCSV00 – Saphenous Vein Allograft without Competent Valve
PCSV10 – Saphenous Vein Allograft with Competent Valve
Diameter: 3mm+ OD
Length: 12cm-16cm

Place an order or ask technical questions any time (24 hours, 365 days a year)
by calling 1-888-427-9654.

References

  1. Briceno-Medina M, et al. Poster presentation at 2016 Western Thoracic Surgical Society Annual Meeting.
  2. Takeuchi K, et al. Interactive Cardiovasc and Thorac Surg, 2006; 5:345-348.